Stock VELO VELOXIS PHARMACEUTICALS A/S
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Veloxis Pharmaceuticals A/S

Equities

VELO

DK0060048148

Pharmaceuticals

Delayed Nasdaq Copenhagen
Other stock markets
 		5-day change 1st Jan Change
- DKK -.--% Intraday chart for Veloxis Pharmaceuticals A/S -.--% -0.50%
05-30 Veloxis Pharmaceuticals A/S Selects to Present At the 2024 American Transplant Congress in Philadelphia CI
2022 Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD) CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VELO Stock
  4. News Veloxis Pharmaceuticals A/S
  5. MarketScreener Editorial Features
-40% Exceptional Extension: Our subscriptions help you unlock hidden opportunities. Exceptional extension!
BENEFIT NOW
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition